Entera Bio Analyst Price Targets

Wall Street analyst price targets and consensus rating for Entera Bio (ENTX).

Price Target Range — 8 Quarters

Analyst Consensus — 5 Analysts

5Buy

Consensus RatingOutperform# Analysts5Avg. Consensus PT$10Upside to Avg. PT+239.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 25, 2026	Guggenheim	Vamil Divan	Initiate	Buy	$11
Sep 23, 2026	LifeSci Capital	Patrick Dolezal	Initiate	Outperform	$10
Sep 22, 2026	Cantor Fitzgerald	Imogen Mansfield	Initiate	Overweight	—
Sep 18, 2026	Leerink Partners	David Risinger	Initiate	Outperform	$9
Apr 27, 2026	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$10→$9
Feb 9, 2026	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
Mar 18, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
Nov 11, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
Oct 7, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
Sep 27, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
Aug 12, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
Jun 5, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
May 14, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
May 13, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
Apr 2, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
Dec 11, 2023	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10

Analyst Ratings News

PRO
Guggenheim Initiates Coverage On Entera Bio with Buy Rating, Announces Price Target of $11

Guggenheim analyst Vamil Divan initiates coverage on Entera Bio (NASDAQ:ENTX) with a Buy rating and announces Price Target of $11.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Initiates Coverage On Entera Bio with Overweight Rating

Cantor Fitzgerald analyst Imogen Mansfield initiates coverage on Entera Bio (NASDAQ:ENTX) with a Overweight rating.

Benzinga Newsdesk

PRO
Leerink Partners Initiates Coverage On Entera Bio with Outperform Rating, Announces Price Target of $9

Leerink Partners analyst David Risinger initiates coverage on Entera Bio (NASDAQ:ENTX) with a Outperform rating and announces Price Target of $9.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Entera Bio, Lowers Price Target to $9

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Entera Bio (NASDAQ:ENTX) with a Buy and lowers the price target from $10 to $9.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Entera Bio (NASDAQ:ENTX) with a Buy and maintains $10 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Entera Bio (NASDAQ:ENTX) with a Buy and maintains $10 price target.

Benzinga Newsdesk

Entera Bio Ltd

ニュース

パートナーシップ

ベンジンガ・グローバル

Entera Bio Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Guggenheim Initiates Coverage On Entera Bio with Buy Rating, Announces Price Target of $11

PRO
Cantor Fitzgerald Initiates Coverage On Entera Bio with Overweight Rating

PRO
Leerink Partners Initiates Coverage On Entera Bio with Outperform Rating, Announces Price Target of $9

PRO
HC Wainwright & Co. Maintains Buy on Entera Bio, Lowers Price Target to $9

PRO
HC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target

People Also Watch

People Also Watch

Entera Bio Ltd

ニュース

パートナーシップ

ベンジンガ・グローバル

Entera Bio Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROGuggenheim Initiates Coverage On Entera Bio with Buy Rating, Announces Price Target of $11

PROCantor Fitzgerald Initiates Coverage On Entera Bio with Overweight Rating

PROLeerink Partners Initiates Coverage On Entera Bio with Outperform Rating, Announces Price Target of $9

PROHC Wainwright & Co. Maintains Buy on Entera Bio, Lowers Price Target to $9

PROHC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target

PROHC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target

People Also Watch

People Also Watch

PRO
Guggenheim Initiates Coverage On Entera Bio with Buy Rating, Announces Price Target of $11

PRO
Cantor Fitzgerald Initiates Coverage On Entera Bio with Overweight Rating

PRO
Leerink Partners Initiates Coverage On Entera Bio with Outperform Rating, Announces Price Target of $9

PRO
HC Wainwright & Co. Maintains Buy on Entera Bio, Lowers Price Target to $9

PRO
HC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target